Medical Equipment

Insulin Delivery Devices Market 2025–2029: Strategic Opportunities and Growth Insights

December 8, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the insulin delivery devices market from 2025–2034 with trusted insights from The Business Research Company

What Are The Market Size Estimates For The Insulin Delivery Devices Market Now And By 2029?

The insulin delivery devices market size has seen strong expansion over recent years. This market is expected to increase from $17.71 billion in 2024 to $19.07 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.7%. The growth observed in the past can be attributed to the convenience and ease of use provided by insulin delivery devices, beneficial reimbursement policies, the rising prevalence of obesity, an expanding aging population, and the increasing embrace of insulin pumps.

The insulin delivery devices market is anticipated to show significant expansion over the next few years. It is projected to reach $25.98 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.0%. This observed growth within the forecast period can be attributed to the rising prevalence of the diabetic population, increasing healthcare expenditure on diabetes care, the emergence of continuous glucose monitoring systems, a growing awareness among patients regarding the benefits of automated insulin delivery devices, and an enhanced focus on healthcare. Key trends during this period are expected to include technological advancements in insulin delivery devices, the integration of digital technology with these devices, the development of artificial pancreas systems, innovations in insulin administration technology, and advancements in bionic technology.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18642&type=smp

Which Long-Term Drivers Are Expected To Sustain The Insulin Delivery Devices Market?

The increasing incidence of diabetes is projected to drive expansion within the insulin delivery devices market in the future. This chronic ailment is characterized by elevated blood sugar, resulting from either insufficient insulin creation by the pancreas or the body’s impaired capacity to use insulin properly. The rise in diabetes diagnoses is largely attributed to factors like inactive lifestyles, poor dietary habits, and a global surge in obesity. These devices are essential for individuals with diabetes, facilitating the effective management of blood sugar through controlled and convenient insulin administration, which helps prevent complications and supports overall well-being. For example, data from December 2022, provided by the US government agency, the Centers for Disease Control and Prevention, suggests that the population of young individuals under 20 diagnosed with type 2 diabetes in the United States could see an almost 700% increase by 2060, potentially reaching 220,000 people. During this identical timeframe, new diagnoses of type 1 diabetes among this young demographic might increase by up to 65%. Consequently, the expanding occurrence of diabetes is fueling the growth of the insulin delivery devices market.

How Is The Insulin Delivery Devices Market Classified By Different Segments?

The insulin delivery devicesmarket covered in this report is segmented –

1) By Type: Insulin Syringes, Insulin Jet Injectors, Pen Needles, Reusable Insulin Pens, Disposable Insulin Pens, Insulin Pumps, External Or Tethered Pumps, Patch Pumps

2) By Disease Indication: Type 1, Type 2

3) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Sales, Diabetes Clinics Or Centers

Subsegments:

1) By Insulin Syringes: Standard Insulin Syringes, Insulin Syringes With Fixed Or Adjustable Needle Length

2) By Insulin Jet Injectors: Needle-Free Insulin Jet Injectors, High-Pressure Insulin Jet Injectors

3) By Pen Needles: Short Pen Needles, Long Pen Needles

4) By Reusable Insulin Pens: Reusable Pens With Replaceable Cartridges, Refillable Insulin Pens

5) By Disposable Insulin Pens: Single-Use Disposable Insulin Pens, Pre-Filled Disposable Insulin Pens

6) By Insulin Pumps: Traditional Insulin Pumps, Smart Insulin Pumps

7) By External Or Tethered Pumps: Traditional External Insulin Pumps, Wireless Tethered Pumps

8) By Patch Pumps: Patch Insulin Pumps, Integrated Patch Pumps

What Current And Upcoming Trends Are Shaping The Insulin Delivery Devices Market?

Leading companies within the insulin delivery devices market are developing innovative solutions, such as insulin pumps, to ensure continuous or personalized insulin provision. These insulin pumps are programmable medical devices designed to deliver insulin without interruption or on an as-needed basis via a catheter placed under the skin. For example, in May 2023, Beta Bionics, a US-based medical technology company, announced that the U.S. Food and Drug Administration had approved its iLet ACE Pump and iLet Dosing Decision Software. The iLet Bionic Pancreas system is intended for individuals aged six and older living with type 1 diabetes, combining two devices with a compatible FDA-cleared integrated continuous glucose monitor (iCGM). It operates through an automated insulin dosing (AID) system, driven by an adaptive closed-loop algorithm that initially only requires the user’s body weight for setup, thereby eliminating the need for additional insulin dosing parameters. Distinct from traditional pump therapy, this system requires no manual adjustment of settings, which simplifies both its initiation and ongoing management. The iLet device also features a meal announcement capability that streamlines mealtime insulin dosing by allowing users to categorize meals as small, medium, or large, with the algorithm learning and adapting to individual insulin requirements over time.

Who Are The Primary Market Leaders In The Insulin Delivery Devices Market?

Major companies operating in the insulin delivery devices market are Sanofi SA, Abbott Laboratories, F. Hoffmann-La Roche Ltd., Medtronic Plc, Eli Lilly and Company, Novo Nordisk A/S, Becton, Dickinson and Company, EOFlow Co. Ltd., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed Holding AG, Xeris Pharmaceuticals Inc., Beta Bionics Inc., Zealand Pharma AS, Bigfoot Biomedical Inc., Emperra GmbH, Animas Corporation, Debiotech SA, CeQur Corporation, Aerami Therapeutics Inc., Alshifa Medical Group, AMF Medical SA, Andain Inc., Avecho Biotechnology Ltd., Apex Medical Devices

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/insulin-delivery-devices-global-market-report

Which Regional Markets Are Emerging As Key Centers For The Insulin Delivery Devices Market?

North America was the largest region in the insulin delivery devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=18642&type=smp

Browse Through More Reports Similar to the Global Insulin Delivery Devices Market 2025, By The Business Research Company

Insulin Pens Syringes Pumps And Injectors Market 2025

https://www.thebusinessresearchcompany.com/report/insulin-pens-syringes-pumps-and-injectors-market

Insulin Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/insulin-drugs-global-market-report

Smart Insulin Pens Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/smart-insulin-pens-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795